For: | Chen JG, Cai J, Wu HL, Xu H, Zhang YX, Chen C, Wang Q, Xu J, Yuan XL. Colorectal cancer screening: Comparison of transferrin and immuno fecal occult blood test. World J Gastroenterol 2012; 18(21): 2682-2688 [PMID: 22690078 DOI: 10.3748/wjg.v18.i21.2682] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i21/2682.htm |
Number | Citing Articles |
1 |
Jong-Mi Lee, Mi Jung Park, Woong Heo, Kang Gyun Park, Yong Gyu Park, Seung Beom Han, Young-Seok Cho, Yeon-Joon Park. Clinical Utility of Fecal Immunochemical Transferrin Test in Gastrointestinal Bleeding Detection. Annals of Clinical Microbiology 2018; 21(3): 51 doi: 10.5145/ACM.2018.21.3.51
|
2 |
Sarah Cheuk Hei Chan, Jessie Qiaoyi Liang. Advances in tests for colorectal cancer screening and diagnosis. Expert Review of Molecular Diagnostics 2022; 22(4): 449 doi: 10.1080/14737159.2022.2065197
|
3 |
Anton Gies, Katarina Cuk, Petra Schrotz-King, Hermann Brenner. Fecal immunochemical test for hemoglobin in combination with fecal transferrin in colorectal cancer screening. United European Gastroenterology Journal 2018; 6(8): 1223 doi: 10.1177/2050640618784053
|
4 |
Hao Li, Kamala Vanarsa, Ting Zhang, Sanam Soomro, Pietro Antonio Cicalese, Valeria Duran, Shobha Dasari, Kyung Hyun Lee, Claudia Pedroza, John B. Kisiel, Huanlong Qin, Robert S. Bresalier, Nicholas Chia, Chandra Mohan. Comprehensive aptamer-based screen of 1317 proteins uncovers improved stool protein markers of colorectal cancer. Journal of Gastroenterology 2021; 56(7): 659 doi: 10.1007/s00535-021-01795-y
|
5 |
Magdalen R.R. Carroll, Helen E. Seaman, Stephen P. Halloran. Tests and investigations for colorectal cancer screening. Clinical Biochemistry 2014; 47(10-11): 921 doi: 10.1016/j.clinbiochem.2014.04.019
|
6 |
Tao Zeng, Zhongchao Huang, Xufa Yu, Li Zheng, Tao Liu, Boyu Tian, Siyu Xiao, Jiahui Huang. Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1166796
|
7 |
Minghao Sun, Jie Liu, Hao Hu, Peng Guo, Zhili Shan, Hengying Yang, Junyi Wang, Wen Xiao, Xiaojun Zhou. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population. Journal of Cancer Research and Clinical Oncology 2019; 145(10): 2423 doi: 10.1007/s00432-019-02992-2
|
8 |
Yoshikatsu Koga, Nobuyoshi Yamazaki, Yasuhiro Matsumura. New molecular diagnosis and screening methods for colorectal cancer using fecal protein, DNA and RNA. Expert Review of Molecular Diagnostics 2014; 14(1): 107 doi: 10.1586/14737159.2014.863152
|
9 |
Ran Zhao, Dongge Xia, Yingwei Chen, Zhentian Kai, Fangying Ruan, Chaoran Xia, Jingkai Gong, Jun Wu, Xueliang Wang. Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19‐9, gender, and age. Cancer Medicine 2023; 12(13): 14636 doi: 10.1002/cam4.6067
|
10 |
Ming-Jen Sheu, Mei-Chen Yeh, Ming-Chang Tsai, Chi-Chih Wang, Yen-Ling Chang, Chau-Jong Wang, Hui-Pei Huang. Glucosinolates Extracts from Brassica juncea Ameliorate HFD-Induced Non-Alcoholic Steatohepatitis. Nutrients 2023; 15(16): 3497 doi: 10.3390/nu15163497
|
11 |
Wael L.L. Demian, Stacy Collins, Candace Fowler, Jerry McGrath, Scott Antle, Zoë Moores, Deborah Hollohan, Suzanne Lacey, Joseph Banoub, Edward Randell. Evaluation of the analytical performance of the novel NS-Prime system and examination of temperature stability of fecal transferrin compared with fecal hemoglobin as biomarkers in a colon cancer screening program. Practical Laboratory Medicine 2015; 2: 29 doi: 10.1016/j.plabm.2015.07.002
|
12 |
Kamil Strzelak, Natalia Rybkowska, Agnieszka Wiśniewska, Robert Koncki. Photometric flow analysis system for biomedical investigations of iron/transferrin speciation in human serum. Analytica Chimica Acta 2017; 995: 43 doi: 10.1016/j.aca.2017.10.015
|
13 |
Wen‐Jing Yang, Hai‐Bo Wang, Wen‐Da Wang, Peng‐Yu Bai, Hong‐Xia Lu, Chang‐He Sun, Zi‐Shen Liu, Ding‐Kun Guan, Guo‐Wang Yang, Gan‐Lin Zhang. A network‐based predictive gene expression signature for recurrence risks in stage II colorectal cancer. Cancer Medicine 2020; 9(1): 179 doi: 10.1002/cam4.2642
|
14 |
Gonzalo Hijos-Mallada, Nuria Saura, Alberto Lué, Raúl Velamazan, Rocío Nieto, Mercedes Navarro, Samantha Arechavaleta, Eduardo Chueca, Fernando Gomollon, Angel Lanas, Carlos Sostres. A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer. Cancers 2023; 15(3): 721 doi: 10.3390/cancers15030721
|
15 |
葵花 卢. The Screening for Colorectal Cancer on the Basis of Feces. Advances in Clinical Medicine 2018; 8(06): 590 doi: 10.12677/ACM.2018.86099
|
16 |
Graeme P. Young, Erin L. Symonds, James E. Allison, Stephen R. Cole, Callum G. Fraser, Stephen P. Halloran, Ernst J. Kuipers, Helen E. Seaman. Advances in Fecal Occult Blood Tests: The FIT Revolution. Digestive Diseases and Sciences 2015; 60(3): 609 doi: 10.1007/s10620-014-3445-3
|